QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Similar Efficacy and Safety of Biosimilar Candidate IBI303 and Reference Products of Adalimumab in Patients with Ankylosing Spondylitis: Results from a Randomized, Double-Blind, Phase III Study 期刊论文 ARTHRITIS & RHEUMATOLOGY, 2018, 卷号: 70 作者:  Wu, Lijun;  Xu Huji;  Li Zhijun;  Jian, Wu;  Qian, Xing 收藏  |  浏览/下载：26/0  |  提交时间：2019/12/05 Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects 期刊论文 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 卷号: 82, 期号: 4 作者:  Zhang, Hong;  Li, Qingmei;  Zhu, Xiaoxue;  Li, Cuiyun;  Li, Xiaojiao 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Bevacizumab  Biosimilar  Immunogenicity  Pharmacokinetics  Inter-subject variability   A China-manufactured bevacizumab biosimilar, HLX04, matches bevacizumab sourced from China, USA and the European Union 会议论文 作者:  Ding, Y.;  Yu, T.;  Sun, J.;  Wu, M.;  Chen, Q. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文 作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y. 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文 作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文 作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文 作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y. 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation 期刊论文 CARBOHYDRATE POLYMERS, 2018, 卷号: 197, 页码: 83-91 作者:  Xie, Shaoshuai;  Guan, Yudong;  Zhu, Peipei;  Li, Fei;  Yu, Mengqi 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 LMWHs  Dalteparin  Porcine intestinal heparin  Bovine lung heparin  Ovine intestinal heparin  Biosimilar   First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 期刊论文 2018, 卷号: 29 作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y. 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 Variability of intended copies for etanercept (Enbrel (R)): Data on multiple batches of seven products 期刊论文 2018, 卷号: 10, 期号: 1, 页码: 166-176 作者:  Hassett, Brian;  Scheinberg, Morton;  Castaneda-Hernandez, Gilberto;  Li, Mengtao;  Rao, Uppuluri R. K. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 biosimilar  characterization  comparability  etanercept  intended copy  quality attribute